Enjeux des licences de développement de médicaments de seconde génération - The Stakes of Licences for the Development of Second Generation Drugs

As part of the optimisation of the drug life cycle, pharmaceutical laboratories are now developing second generation drugs which are often new formulations or presentations which improve on the profile of the drug, in particular in terms of efficacy or tolerance, for example an oral rather than an injectable form, or a slow release form enabling a reduction in the number of doses per day, etc. Second generation drugs can also be combinations of active principles.